glp-1 suicide The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy New study confirms GLP-1 medications

Juraszek, B., & Nacz, K

A 2000 study on female rats found that 12 weeks of this compound increased bone mineral content in the tibia and vertebrae, though this was linked to overall body weight gain, indicating its effects may be tied to general growth promotion (10)

A practical pre-treatment checklist Confirm whether you already have diabetic retinopathy or diabetic macular edema Tell your endocrinologist or primary physician if you are under retina care Tell your eye doctor if you are about to start semaglutide or another GLP-1 drug Update your dilated eye exam if it is overdue Document baseline symptoms such as blur, floaters, or metamorphopsia This creates a baseline

Helps fade hyperpigmentation such as age spots, melasma, and freckles

Moreover, our data demonstrate that the activity of CAT was upregulated, especially in WCM and 100 mM NaCl + WCM